Novartis Malaysia's CVD commitment recognised at regional PR awards

KUALA LUMPUR: Novartis Malaysia’s commitment to changing the treatment paradigms of cardiovascular disease (CVD) outcomes in Malaysia was recognised at the recent regional level Marketing-Interactive PR Awards 2024.

© New Straits Times Press (M) Bhd